According to US experts, people with diabetes prescribed semaglutide were four times more likely to be diagnosed with non-arteritic anterior ischemic optic neuropathy. According to US experts, people with diabetes prescribed semaglutide were four times more likely to be diagnosed with non-arteritic anterior ischemic optic neuropathy.